EHC / Encompass Health's (EHC) CEO Mark Tarr on Q1 2022 Results - Earnings Call Transcript

Encompass Health (EHC) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement more_horizontal

Encompass Health's (EHC) Q3 results benefit from an increase in patient volumes and net patient revenue per discharge. Management currently projects a more_horizontal

While the top- and bottom-line numbers for Encompass Health (EHC) give a sense of how the business performed in the quarter ended September 2023, it c more_horizontal

Encompass Health's (EHC) Q3 results are likely to reflect improved inpatient volumes and bed additions, offset by higher operating expenses. more_horizontal

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Neverthe more_horizontal

Encompass Health (EHC) is well-poised for growth on the back of growing revenues, an aging U.S. population, joint ventures and solid cash reserves. more_horizontal

Here is how Encompass Health (EHC) and Eton Pharmaceuticals, Inc. (ETON) have performed compared to their sector so far this year. more_horizontal

The Rehabilitation Hospital of Columbus is Encompass Health's (EHC) sixth location in the state of Georgia. more_horizontal